BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 9356012)

  • 1. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
    Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
    Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
    Hevener AL; Reichart D; Janez A; Olefsky J
    Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
    Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
    Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
    Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
    J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
    Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
    Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
    Oshida Y; Kako M; Nakai N; Shimomura Y; Li L; Sato J; Ohsawa I; Sato Y
    Endocr J; 1999 Oct; 46(5):723-30. PubMed ID: 10670760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of troglitazone on in vivo insulin action in normal rats.
    Lee MK; Olefsky JM
    Metabolism; 1995 Sep; 44(9):1166-9. PubMed ID: 7666790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatments for GH-induced insulin resistance.
    Sugimoto M; Takeda N; Hattori J; Yoshino K; Nakashima K; Okumura S; Ishimori M; Yasuda K
    Endocr J; 1999 Mar; 46 Suppl():S51-3. PubMed ID: 12054120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
    Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
    Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
    Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
    J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone enhances glucose uptake induced by alpha-adrenoceptor stimulation via phosphatidylinositol 3-kinase in rat heart.
    Yoshioka J; Kusuoka H; Imahashi K; Hashimoto K; Hori M; Terakawa T; Nishimura T
    Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):752-7. PubMed ID: 11553036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter.
    Mokuda O; Sakamoto Y
    Diabetes Metab; 1998 Sep; 24(4):362-4. PubMed ID: 9805648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
    Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
    Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
    Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
    Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats.
    Sugimoto M; Takeda N; Nakashima K; Okumura S; Takami K; Yoshino K; Hattori J; Ishimori M; Takami R; Sasaki A; Yasuda K
    Metabolism; 1998 Jul; 47(7):783-7. PubMed ID: 9667221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.